INS and obesity disorder: Obesity is a major component of the metabolic syndrome and has been shown to contribute directly to hepatic steatosis through mechanisms involving increased free fatty acid (FFA) flux, insulin resistance, and proinflammatory cytokine production in MASLD [20].